The clinical utility of Ki‐67 in assessing tumor biology and aggressiveness in patients with appendiceal carcinoids
暂无分享,去创建一个
C. Divino | G. Mamikunian | A. Vinik | V. Go | E. Woltering | T. O'Dorisio | E. Lindholm | Ying Zhou | Gang Li | S. Joseph | Eric Liu | Dana A. Telem | John Hwang | Richard R.P. Warner | Andrew Dikman
[1] G. Mamikunian,et al. Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients , 2008, Pancreas.
[2] G. Mamikunian,et al. Effect of Octreotide LAR Dose and Weight on Octreotide Blood Levels in Patients With Neuroendocrine Tumors , 2005, Pancreas.